Making sense of a novel RC3H1 nonsense mutation associated with Hemopagocytic Lymphohistocytosis (HLH)

Dr Vicki Athanasopoulos, The Vinuesa Group, JCSMR

and

The Aryl Hydrocarbon Receptor (AhR)-dependant cytotoxic reprogramming of CD4+ T cells

Mr Hao Wang, The Yu Group, JCSMR